Khiron Life Sciences Expands CBD-Based Wellness Product Portfolio With Additional Authorizations from Colombian National Food and Drug Surveillance Institute (INVIMA)

TORONTO, July 5, 2018 – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN), a Canadian integrated medical cannabis company with its core operations in Colombia, announced today that further to its announcement of May 30, 2018, the Colombia National Food and Drug Surveillance Institute (“INVIMA”) has granted Khiron authorization for the production, sale and export of